Skip to main content
SpringerLink
Log in

Relationship of serum and tumor levels of iron and iron-binding proteins to lymphocyte immunity against tumor antigen in breast cancer patients

  • Brief communication
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Summary

Fifty-two breast cancer patients were evaluated for levels of several molecules related to iron metabolism including determining their tumor tissue and serum ferritin levels, serum transferrin levels, and serum iron levels. In addition the patients' lymphocyte immunity against autologous tumor antigen was investigated. Forty percent (21 of 52) of the patients had lymphocyte immunity against tumor antigen. Iron metabolism molecules were expressed in abnormal quantities in some breast cancer patients: 27% (13 of 49) had elevated tumor tissue ferritin levels, 4% (2 of 49) had abnormally high serum ferritin, 10% (5 of 49) had abnormally low serum transferrin levels, and 43% (21 of 49) had depressed serum iron levels. None of these abnormalities in iron metabolism are associated with tumor immunity. These iron metabolism molecules may be indicative of rates of cell proliferation or may influence growth of breast cancer cells, but do not appear to influence host lymphocyte immunity against tumor associated antigens.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Dean JH, McCoy JL, Cannon GB, Leonard CM, Perlins E, Kreutner A: Cell-mediated immune response of breast cancer patients to autologous tumor-associated antigens. J Nat Cancer Inst 58: 549–555, 1977

    Google Scholar 

  2. Head JF, Wang F, Elliott RL, McCoy JL: Assessment of immunological competence and host reactivity against tumor antigens in breast cancer patients: Prognostic value and rationale of immunotherapy development. Ann New York Acad Sci 160: 340–342, 1993

    Google Scholar 

  3. Head JF, Elliott RL, McCoy JL: Evaluation of lymphocyte immunity in breast cancer patients. Breast Cancer Res Treat 26: 77–88, 1993

    Google Scholar 

  4. Brock JH: Iron and the immune system. In: Lauffer RB (ed) Iron and Human Disease. CRC Press, Boca Raton, 1992, pp 161–178

    Google Scholar 

  5. Marcus DM, Zinberg N: Measurement of serum ferritin by radioimmunoassay: Results in normal individuals and patients with breast cancer. J Nat Cancer Inst 55: 791–795, 1975

    Google Scholar 

  6. Jacobs A, Jones B, Ricketts C, Bulbrook RD, Wang DY: Serum ferritin concentration in early breast cancer. Br J Cancer 34: 286–290, 1976

    Google Scholar 

  7. Weinstein RE, Bond BH, Silberberg BK: Tissue ferritin concentration in carcinoma of the breast. Cancer 50: 2406–2409, 1982

    Google Scholar 

  8. Rossiello R, Carriero MV, Giordano GG: Distribution of ferritin, transferrin and lactoferrin in breast carcinoma tissue. J Clin Path 37: 51–55, 1984

    Google Scholar 

  9. Elliott RL, Ledford L, Werneke D, Elliott MC: Tissue ferritin concentration in breast carcinoma: A possible marker of proliferative index (a cytosol and electron microscopy study). Proc Annual Meeting of Elec Micros Soc Am 47: 852, 1986

    Google Scholar 

  10. Weinstein RE, Bond BH, Silberberg BK, Vaughn CB, Subbaiah P, Pieper DR: Tissue ferritin concentration and prognosis in carcinoma of the breast. Breast Cancer Res Treat 14: 349–353, 1989

    Google Scholar 

  11. Rizzino A, Sato G: Growth of embryonal carcinoma cells in serum free medium. Proc Natl Acad Sci USA 5: 1844–1848, 1978

    Google Scholar 

  12. Faulk WP, Hsi B-L, Stevens PJ: Transferrin and transferrin receptors in carcinoma of the breast. Lancet ii: 390–392, 1980

    Google Scholar 

  13. Lamoureux G, Mandeville R, Poisson R, Poisson-Legault S, Jolicoeur R: Biological markers and breast cancer. A multiparametric study. Increased serum protein levels. Cancer 49: 502–512, 1982

    Google Scholar 

  14. Matzner Y, Hershko C, Polliack A, Konijn AM, Izak G: Suppressive effect of ferritin onin vitro lymphocyte function. Br J Hemat 42: 345–353, 1979

    Google Scholar 

  15. Cazzola M, Arosio P, Bellotto V, Bergamschi G, Dezza L, Iacobello C, Ruggeri G, Zappone E, Albertini A, Ascari E: Immunological reactivity of serum ferritin in patients with malignancy. Tumori 71: 547–554, 1985

    Google Scholar 

  16. Moroz C, Giler S, Kupfer B, Urca I: Lymphocyte bearing surface ferritin in patients with Hodgkin's disease and breast cancer. N Engl J Med 296: 1172–1173, 1977

    Google Scholar 

  17. Neckers LM, Cossman J: Transferrin receptor induction in mitogen stimulated T lymphocytes is required for DNA synthesis and cell division and is regulated by IL-2. Proc Natl Acad Sci USA 80: 3494–3498, 1983

    Google Scholar 

  18. Oren ME, Herberman RB: Delayed cutaneous hypersensitivity reactions to membrane extracts of human tumors. Clin Exp Immunol 9: 45–56, 1971

    Google Scholar 

  19. Morita R, Yoshii M, Nakajima K, Kohsaka T, Miki M, Torizuka K: Clinical evaluation of serum ferritin to iron ratio in malignant disease. Eur J Nucl Med 6: 331–336, 1981

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Elliott Mastology Center, 1770 Physicians Park Drive, 70816, Baton Rouge, LA, USA

    Robert L. Elliott & Jonathan F. Head

  2. ImmuQuest Laboratories, 362-C Christopher Avenue, 20879, Gaithersburg, MD, USA

    James L. McCoy

Authors
  1. Robert L. Elliott
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jonathan F. Head
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. James L. McCoy
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Elliott, R.L., Head, J.F. & McCoy, J.L. Relationship of serum and tumor levels of iron and iron-binding proteins to lymphocyte immunity against tumor antigen in breast cancer patients. Breast Cancer Res Tr 30, 305–309 (1994). https://doi.org/10.1007/BF00665972

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00665972

Key words

Search

Navigation